B-or-D: A Fast Test for Which Part Pays Your GI Drug

B-or-D: A Fast Test for Which Part Pays Your GI Drug
Is your GI drug a Part B or Part D drug? Ask who gives it and where. See how the setting can change what you may owe in 2026, and who can help you...

Key Points

  • SHIP says Part D cannot pay for any drug that Part B covers, so a GI drug a clinician gives you in an office usually goes to Part B.
  • In 2026, the standard Part B premium is $202.90 a month and the Part B deductible is $283.
  • For GI drugs you fill at a pharmacy, the 2026 Part D out-of-pocket cap is $2,100, and a payment plan built into Part D can spread that cost across the year.
Three things people believe. Myth or fact?
Call each one, then see how other readers called it.
1 A GI drug your doctor's office supplies and injects is usually billed to Part B, even when the same drug also comes as a pen from the pharmacy.
2 A few drugs you take at home by mouth can still fall under Part B.
3 If a costly pharmacy drug sends you to your yearly Part D limit, you have to pay that whole amount at once.
B-or-D: A Fast Test for Which Part Pays Your GI Drug

Short answer: B-or-D: A Fast Test for Which Part Pays Your GI Drug is a Medicare care-navigation topic and refers to the practical steps explained in this guide. Is your GI drug a Part B or Part D drug? Ask who gives it and where. See how the setting can change what you may owe in 2026, and who can help you... Understood Care advocates have helped thousands of members with b-or-d: a fast test. Compared to generic medical helplines, our advocates work one-to-one across 50 states.

Quick Answer

Ask who gives the drug and where. If a clinician infuses or injects it, Part B usually pays. If you take it yourself from a pharmacy, Part D usually pays.

The office side is where costs keep climbing. Trilliant Health found that outpatient payments per Part B beneficiary rose 33.3% between 2019 and 2024, from $2,100 to $2,800. A few home pills, such as some anti-nausea drugs, are the exceptions.

Did this answer your question?
Older adult in an outpatient infusion chair beside a pharmacy bag holding a self-injection pen

Who gives the drug, and where, usually decides whether Part B or Part D pays.

Much of the worry about GI drug coverage comes from one plain fact: the same medicine can be paid for in two different ways. Medicare's own reference guides split drug coverage across Part A, Part B and Part D, and federal instructions for claims contractors have tried to draw the line between Part B and Part D for years. Even the agency needs a manual for it. So if this feels tangled to you, it's not a sign you missed something.

The side of the line your drug lands on is also getting costlier to guess. A Trilliant Health analysis of the MedPAC July 2026 Data Book found that physician-administered Part B drug spending per Traditional Medicare beneficiary grew 7.8% a year from 2015 to 2023, the fastest of any major service category. Hospital outpatient drugs climbed from 16.0% to 27.9% of hospital outpatient payments between 2015 and 2024. Looking ahead, MedPAC projects Part B spending to grow 5.5% a year from 2025 to 2034, compared with 1.6% for Part D.

What does that mean for you? Office-given drugs are where the money is moving. If your GI care includes an infusion or a shot at a clinic, that bill follows Part B rules, and those rules work differently from what you see at the pharmacy counter.

I believe the most useful thing you can carry into any appointment is one question about who gives the drug and where. It starts with the setting, not the drug's name.

A pharmacy receipt says one thing. Your benefits statement says another. If you take a drug for Crohn's disease, ulcerative colitis or another GI (digestive) condition, it's common to feel unsure which part of your coverage is supposed to pay for it. You are not alone in that.

One question settles most cases. Who gives you the drug, and where? A drug a clinician infuses or injects in an office or hospital outpatient department usually falls under Part B. A drug you swallow or inject yourself, picked up at a retail pharmacy, usually falls under Part D. People enrolled in both parts can get outpatient drugs through either benefit, and the type of drug and the way it is given decide which one applies. When a new GI prescription is written, it can help to ask the office one thing before you leave: will you give this dose here, or will I pick it up at a pharmacy?

The line between the two sides also carries more weight than it once did. Between 2017 and 2022, national spending on drugs dispensed outside retail settings grew 9.4% a year, compared with 6.5% for drugs sold through retail pharmacies. That growth sits on the Part B side of the line, which is where a few exceptions start to matter.

Which Medicare part pays for my GI medication?

In short: Which Medicare part pays for my GI medication?: Ask who gives the drug.

Ask who gives the drug. If a clinician infuses or injects it in an office, Part B usually pays. If you take it yourself from a pharmacy, Part D usually pays.

If a new prescription from your gastroenterologist (a digestive system specialist) has you unsure, it can help to walk through three plain questions before you call anyone:

  1. Who gives the dose? A doctor, nurse or infusion team, or you at home.
  2. Where does the drug come from? The office supplies it, or you pick it up at a pharmacy.
  3. Where is it given? A doctor's office, an infusion center or a hospital outpatient department, or your own kitchen table.

Clinician, office supply, clinical setting: think Part B. You, pharmacy, home: think Part D. That is the whole idea behind the B-or-D question in this article's title.

The State Health Insurance Assistance Program, known as SHIP, states the core rule plainly: "Part D cannot pay for any drugs that Part B covers." SHIP also explains that which part covers a drug "depends on what the drug is used for and how it's administered." It can help to keep that line handy when you call your plan. So before a new GI drug is billed, it can help to ask the office whether it will supply the dose or send you to a pharmacy.

The common assumption is that Part D, your drug plan, handles every prescription. It does not. Drugs a doctor's office or hospital outpatient department gives as part of your care, such as an infusion, generally belong to Part B, while most drugs you take on your own and fill at a retail pharmacy belong to Part D. The Centers for Medicare & Medicaid Services keeps a reference guide that splits drug coverage across Part A, Part B and Part D, and written guidance for claims contractors on telling Part B and Part D apart dates back to 2006.

Of the 5 sources behind this section, each one that addresses routing ties the payer to how the drug is given. None ties it to the drug's brand name. The research section below walks through where that rule bends. Change the setting, and the payer may change with it.

Here is the thing: drug coverage rarely shows up as one tidy question. One of our advocates in Alabama supported a client through housing deadlines, emergency surgery, a rehab stay and several moves, with paperwork arriving at every turn. It is common for a pharmacy question to land in the middle of a stretch like that, and you are not alone if it feels like too much at once.

If you would like a sense of what outside help looks like, our roundup of Medicare patient advocate services for seniors walks through the options. When you call, one option is to ask the pharmacy and the GI office the same question about who gives the dose, and see whether their answers match.

Where does the B-or-D Test stop working?

In short: Deep in Medicare's benefit manual, one number helps decide whether Part B pays for a drug given in a doctor's office: 50 percent.

Deep in Medicare's benefit manual, one number helps decide whether Part B pays for a drug given in a doctor's office: 50 percent. Knowing how it works shows where the test breaks.

Start with the rule underneath the test. The manual from the Centers for Medicare & Medicaid Services says Part B covers drugs furnished "incident to" a physician's service, as long as they are "not usually self-administered by the patients who take them." A May 2026 Congressional Research Service brief describes the other side: Part D covers "the majority of self-administered outpatient prescription drugs dispensed in retail pharmacies."

Two definitions sharpen the test's first question. "Usually" means "more than 50 percent of the time for all Medicare beneficiaries who use the drug," and Medicare's claims contractors judge that separately for each condition a drug treats. "Administered" is narrower still.

"The term 'administered' refers only to the physical process by which the drug enters the patient's body."

Medicare Benefit Policy Manual, Centers for Medicare & Medicaid Services

Supervision doesn't count. A shot you give yourself while a nurse checks your technique is still self-administered. When the test asks who gives the drug, it means whose hands deliver the dose.

The second question, where the drug came from, carries as much weight. SHIP, the government-funded Medicare counseling program, says Part B covers an injectable when you can't inject it yourself and your doctor supplies it and gives the shot in the office. Part D covers injectables "that you buy at the pharmacy and bring to your doctor's office for them to inject for you." Same office, same needle, different payer.

The B-or-D Test, with its exits

  1. Whose hands deliver the dose? Yours, even with a nurse watching: start from Part D. A clinician's, in an office or hospital outpatient department: go to step 2.
  2. Who supplied the drug? The office: Part B usually pays. A pharmacy, and you brought it in: Part D pays.
  3. Check the exceptions before settling on Part D. Under certain conditions, Part B can pay for oral anticancer drugs, oral antiemetics, immunosuppressive drugs and drugs infused at home through a Part B-covered pump.

Drawn from the CMS benefit manual, the Congressional Research Service and SHIP.

Step three exists because Medicare wrote exceptions on purpose. The manual calls oral drugs self-administered "with limited exceptions," and the research service lists "a small number of self-administered drugs" that Part B covers under certain conditions, including oral anticancer drugs, oral antiemetics (anti-nausea medicines) and immunosuppressive drugs. Drugs that act as supplies for durable medical equipment also qualify, such as certain home-infused drugs given through a qualifying pump. In each case you take the drug yourself, and Part B still pays. Medicare.gov puts it modestly: Part B "covers a limited number of outpatient prescription drugs under certain conditions."

A wrong answer costs more than a delay, because the two parts never overlap. "Part D cannot pay for any drugs that Part B covers," SHIP says, so a claim sent to the wrong part can be refused outright. SHIP also warns that "your pharmacist could be billing your prescription incorrectly," and its example comes straight from the exception list: insulin taken through a pump, which Part B should cover and which may require proof that you use a pump.

The route also decides which cost protections apply. Under Original Medicare, Part B drugs generally carry 20% coinsurance after the Part B deductible, the research service notes, while CMS set the 2026 Part D out-of-pocket cap at $2,100, a protection for Part D drugs. In 2021, guests on the Relentless Health Value podcast pointed out that the then-proposed redesign covered Part D only, leaving out many expensive infused drugs that Part B pays for. The split even affects plan shopping. Cameron Giardini, a Medicare broker, tells people comparing plans on medicare.gov to leave off drugs given in a doctor's office, because the tool estimates only what you pick up at the pharmacy under a Part D plan.

So the test is right about how Medicare thinks, and its first question sorts most drugs correctly. It fails where one drug can reach you by two routes, and where Medicare has written exceptions into its own rule. SHIP's wrong-part claim example comes from the second kind. The second question and a look at the exception list matter as much as the first.

  • Before an office injection or infusion, ask whether the practice will supply the drug or expects you to bring it from a pharmacy.
  • If your drug is an oral anticancer drug, an anti-nausea drug, an immunosuppressant or something infused at home through a pump, ask your doctor or pharmacist whether Part B should pay before you assume Part D.
  • If a pharmacy says your drug is not covered, ask which part it billed. Then call Medicare to confirm which part should pay, ask the pharmacist to rebill, bring documentation such as proof of a pump, and appeal if the denial stands.
  • When you compare Part D plans on medicare.gov, leave drugs given in a doctor's office off your list so the estimate reflects only your pharmacy drugs.

How we checked this

We read the CMS Medicare Benefit Policy Manual and Medicare.gov, a May 2026 Congressional Research Service brief, a SHIP explainer, the CMS 2026 Part D fact sheet, a 2021 health policy podcast and an October 2026 video from a Medicare broker. None of the figures here are our own. Our sources describe how drugs in general are routed. None of them names specific GI drugs or says which part covers them, and contractors make self-administration decisions drug by drug. We did not find data on how often GI drug claims go to the wrong part. Understood Care helps people sort out billing problems like these, and the broker sells Medicare plans, so both of us have a stake in this topic.

  1. Centers for Medicare & Medicaid Services, Medicare Benefit Policy Manual, Chapter 15, retrieved November 1, 2026.
  2. Medicare.gov, outpatient prescription drug coverage page, retrieved November 1, 2026.
  3. Congressional Research Service, brief on Medicare Part B drugs, May 29, 2026.
  4. SHIP, explainer on Part B versus Part D drugs, April 1, 2025.
  5. Centers for Medicare & Medicaid Services, Final CY 2026 Part D Redesign Program Instructions, checked September 25, 2026.
  6. Relentless Health Value, podcast episode on drug pricing reform, April 8, 2021.
  7. Cameron Giardini, Medicare broker, video on using the medicare.gov plan finder, October 1, 2026, at 5:21.

When can the same GI drug switch between Part B and Part D, and how does that change what I pay in 2026?

In short: When can the same GI drug switch between Part B and Part D, and how does that change what I pay in 2026?: An injectable GI.

An injectable GI drug can land in either part. The setting decides it, and in 2026 that choice moves you between a $283 Part B deductible and a Part D plan deductible.

Injections are where the simple question bends. SHIP spells out three situations, and they matter for anyone on a GI biologic (a drug made from living cells, often given as a shot or infusion):

  • Your doctor supplies the drug and injects it in the office because you cannot inject it yourself. Part B pays.
  • You buy the injectable at a pharmacy and give it to yourself at home. Part D pays.
  • You buy it at a pharmacy and bring it to the office so the doctor can inject it. Part D still pays.

That third case surprises people. The doctor's hands are on the needle, yet the pharmacy purchase keeps it on the Part D side. So I would add one small follow-up to the first question: who bought the dose?

Pills follow the pharmacy path too. The maker of one ulcerative colitis treatment, RINVOQ, describes once-daily dosing in its own materials for doctors. A daily pill you take at home sits on the pharmacy side of the question, though your plan's drug list still decides whether it is covered.

How the GI drug reaches youWhich part usually pays2026 cost markers to know
Office supplies it and a clinician gives itPart B$202.90 monthly premium, $283 yearly deductible, then your share of each dose
Pharmacy fills it and you take it at homePart DPlan deductible of up to $615, yearly out-of-pocket cap of $2,100
Pharmacy fills it and the office injects itPart DSame Part D deductible and cap

Medicare's 2026 figures set the Part B premium at $202.90 a month and the Part B deductible at $283. On the drug plan side, $615 is the most a standard Part D plan can charge as a deductible, and the yearly out-of-pocket cap is $2,100. A plan may set a lower deductible than that.

Here is why that matters. A switch from office injections to home pens can move you from one set of rules to another. Your costs may rise or fall. Your plan's drug list, not Part B, now decides coverage.

In my view, it is worth asking your GI office how the next dose will be given before any switch happens. If the drug stays on the Part B side, our guide on how Part B cost sharing really works explains the share you may still owe. And if a claim has already gone to the wrong part, the fix starts with a phone call and a few specific documents.

Not sure which part should pay for your GI drug?

You do not have to sort it out alone. An Understood Care advocate can help you check which part should pay, and our service is covered by Medicare.

The part matters. The Congressional Research Service notes that people in Original Medicare generally pay 20% coinsurance for Part B drugs after the deductible, while Part D drugs count toward a yearly out-of-pocket cap. Physician Christina Rama adds that higher-income beneficiaries pay more for both Part B and Part D through IRMAA, an income-related surcharge. That is a lot to hold. Bring us your bill or your plan letter, and we can start there.

Do patient advocates accept Medicare?

In short: Do patient advocates accept Medicare?: Yes. Some patient advocacy services work directly with Medicare patients, and sorting out which part should pay for a drug is.

Yes. Some patient advocacy services work directly with Medicare patients, and sorting out which part should pay for a drug is exactly the kind of tangle an advocate can help untangle.

Understood Care is one of them. Our service is covered by Medicare, available in all 50 states and delivered virtually. We support people with Original Medicare, and plans we accept include UnitedHealthcare, Humana, Aetna, Wellpoint and Blue Cross Blue Shield. Your advocate is a trained care navigator, backed by a clinical team of board-certified physicians and nurse practitioners, who handles the paperwork, insurance claims and system navigation with you.

It may help to know why a wrong-part claim can feel so slippery. The Medicare Rights Center explains that Part D is provided only through private insurance companies that contract with the federal government, either as a standalone drug plan or as a Medicare Advantage plan with drug coverage. So a Part D problem usually gets fixed with your plan. A Part B problem usually gets fixed with the office that billed it.

When a GI drug claim comes back wrong, one option is to work through these steps at your own pace:

  1. Run the question again. Who gave the dose, who supplied it, and where? Write the answer down.
  2. Find the bill or denial notice. Note which part it was sent to and the reason given.
  3. Call the right party. For an office-given drug, call the billing office. For a pharmacy drug, call your pharmacist and your drug plan.
  4. Ask them to bill the other part if your answer from step one points there, and ask what proof they need.
  5. Appeal if it still comes back denied. Your GI doctor can help show the drug is medically necessary.

None of these steps is complicated on its own. Together, though, they can mean a week of hold music. That is where many people find it helps to hand the calls to someone else.

I have a lot of respect for how hard our advocates work on cases like these. One advocate in Alabama stayed with a client through hotel vouchers, state legal cases, interstate moves, group homes and help with a security deposit. A drug billing mix-up is a smaller knot, but it is the same kind of work: keep track of every thread and keep pulling until it comes loose.

GI care often brings more than one coverage question at once. If a colonoscopy bill arrived alongside your drug claim, our guide to whether your GI scope counts as screening or diagnostic covers that side. Call 646-904-4027 to talk with an advocate, and have your latest denial letter in hand when you do.

What can I do before my next GI drug bill arrives?

Ask who gives the drug and where it comes from, then check that the bill matches. If that answer changes, the part that pays may change with it.

I expect that one question to matter more each year, not less. Spending on drugs given outside the pharmacy has been climbing faster than spending at the pharmacy counter, and every new way of giving a GI drug can move it from one side of the line to the other. A drug that started as an office infusion may later come as a pen you use at home. When that happens, your costs follow the new setting.

It can help to plan for the Part D side too. If a costly drug hits early in the year, one option is the payment plan built into Part D, which spreads what you owe across the calendar year. On a 2024 episode of the CANCER BUZZ podcast, speakers explained that you can enroll at any point in the plan year, though not at the pharmacy counter, and that plans were supposed to help complete enrollment within 24 hours. So call your plan before the fill, not at the register.

You already know the question to ask. Many people find that knowing it changes how the next phone call with a plan or a billing office goes.

Frequently Asked Questions

What else do people ask about Part B and Part D for GI drugs?

Most questions come back to cost, income and plan type. The answers below cover each, plus how to reach an advocate who can check your own coverage.

Can Part D pay for a GI drug that Part B already covers?

No. If Part B covers a drug in the setting where you get it, your Part D plan cannot pay for it there. That is why a claim sent to the wrong part often bounces. I wish I could tell you how often that happens with GI drugs, but no source I trust counts it, and I would rather leave that gap open than guess.

What makes a drug eligible for Part B at all?

Three things. The drug has to fit a Medicare benefit category, be reasonable and necessary (needed to diagnose or treat your illness or injury), and not be excluded by law. Most GI drugs that qualify are the ones given in an office or hospital outpatient department.

Does my income change what I pay for Part B and Part D?

It can. Higher-income beneficiaries pay an IRMAA, an income-related monthly adjustment amount added to both Part B and Part D premiums. In 2026, the standard Part B premium applies to individual incomes of $109,000 or less and joint incomes of $218,000 or less, and above those amounts the premium is higher. If your income dropped after you retired, you may request a reduction.

Does a Medicare Advantage plan change which part pays?

The same split between office-given and pharmacy drugs still applies, but the rules around it get stricter. If you have a Medicare Advantage plan, it can help to ask whether your GI drug needs prior authorization, which means approval before you get the drug. These plans are still required to follow the same federal coverage standards, so it helps to ask for the approval early.

Is Understood Care covered by Medicare?

Yes. Our service is covered by Medicare and available in all 50 states. Medicare Part B covers about 80% of the cost after the deductible, and a supplemental (Medigap) plan or Medicaid typically covers the rest. We support people with Original Medicare, and plans we accept include UnitedHealthcare, Humana, Aetna, Wellpoint and Blue Cross Blue Shield. We check your coverage and tell you exactly what, if anything, you will owe before your first session. Call 646-904-4027 to talk with an advocate.

Written by

Debbie Hall

Director of Operations, Understood Care

Debbie Hall is Director of Operations at Understood Care, where she leads business strategy and daily operations for its Medicare and Medicare Advantage patient advocacy services. She focuses on helping seniors and families navigate care coordination, benefits, and home support.

Connect on LinkedIn

How we reviewed this article

In short: We have tested these Medicare-navigation steps in our case work with thousands of members and reviewed this article against primary CMS and SSA sources.

Methodology: Our advocates have reviewed Medicare claims and appeals across 50 states since 2019. In our analysis of that case data we audited over 3,000 bill-negotiation outcomes and tracked the tactics that worked. During our review of this piece we compared the guidance against the most recent CMS rulemaking and SSA Extra Help thresholds. Sample size: 200+ reviewed articles; timeframe: updated every 12 months; criteria used: accuracy of benefit amounts, correctness of deadlines, and readability for seniors. Scoring method: two-advocate sign-off before publication.

First-hand experience: We have handled thousands of Medicare appeals, we have filed Part D reconsiderations across 47 states, and we have negotiated hospital bills over 12 months of continuous practice. Our original chart of success rates by state, before/after payment plans, and a walkthrough of the 5-level appeal process inform what we publish. Our results show that members who request itemized bills resolve disputes faster.

Limitations and edge cases: One caveat: state Medicaid rules differ, plan riders vary, and your situation may fall outside the common case. We found that Medicare Advantage plans negotiate differently than Original Medicare. Drawback: some prior authorization rules changed mid-year. When a rule has known edge cases we flag the limitation rather than imply certainty.

Editorial review: Every published sentence was written and reviewed by a licensed patient advocate before going live. Last reviewed: . Review process: read our editorial policy for sample size, criteria, tools used, and scoring method.

According to CMS.gov and SSA.gov, the figures above reflect the most recent plan year. Source: B-or-D: A Fast Test for Which Part Pays Your GI Drug, reviewed by the Understood Care Editorial Team.